Lorlatinib Tolerability and Association With Clinical Outcomes in Patients With Advanced ALK- or ROS1-Rearranged NSCLC: A Brief Report
劳拉替尼在ALK或ROS1重排晚期非小细胞肺癌患者中的耐受性及其与临床结局的关系:简要报告
期刊:JTO Clinical and Research Reports
影响因子:3.5
doi:10.1016/j.jtocrr.2023.100546
Thummalapalli, Rohit; Choudhury, Noura J; Ehrich, Fiona; Beardslee, Tyler; Brazel, Danielle; Zhang, Shannon S; Merchant, Shelby; Chen, Monica F; Heller, Glenn; Ramalingam, Suresh S; Ou, Sai-Hong Ignatius; Mileham, Kathryn F; Riely, Gregory J